331 related articles for article (PubMed ID: 29411937)
1. Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.
Heimlich JB; Chipoka G; Elsherif L; David E; Ellis G; Kamthunzi P; Krysiak R; Mafunga P; Zhou Q; Cai J; Gopal S; Key NS; Ataga KI
Pediatr Blood Cancer; 2018 Jun; 65(6):e26993. PubMed ID: 29411937
[TBL] [Abstract][Full Text] [Related]
2. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
3. Novel kidney injury biomarkers in a large cohort of children with sickle cell anemia.
Belisário AR; S Filha RD; de Almeida JA; Mendes FG; Rezende PV; Vieira ÉL; E Silva AC
Biomark Med; 2021 Aug; 15(12):999-1009. PubMed ID: 34289712
[No Abstract] [Full Text] [Related]
4. Renal function in adult Jamaicans with homozygous sickle cell disease.
Asnani MR; Reid ME
Hematology; 2015 Aug; 20(7):422-8. PubMed ID: 25431929
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and albuminuria in children with sickle cell disease.
McPherson Yee M; Jabbar SF; Osunkwo I; Clement L; Lane PA; Eckman JR; Guasch A
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2628-33. PubMed ID: 21940843
[TBL] [Abstract][Full Text] [Related]
6. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.
Zahr RS; Yee ME; Weaver J; Twombley K; Matar RB; Aviles D; Sreedharan R; Rheault MN; Malatesta-Muncher R; Stone H; Srivastava T; Kapur G; Baddi P; Volovelsky O; Pelletier J; Gbadegesin R; Seeherunvong W; Patel HP; Greenbaum LA
Pediatr Nephrol; 2019 Aug; 34(8):1435-1445. PubMed ID: 30945006
[TBL] [Abstract][Full Text] [Related]
7. Nephrinuria associates with multiple renal traits in type 2 diabetes.
Ng DP; Tai BC; Tan E; Leong H; Nurbaya S; Lim XL; Chia KS; Wong CS; Lim WY; Holthöfer H
Nephrol Dial Transplant; 2011 Aug; 26(8):2508-14. PubMed ID: 21196468
[TBL] [Abstract][Full Text] [Related]
8. Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.
Mohtat D; Thomas R; Du Z; Boakye Y; Moulton T; Driscoll C; Woroniecki R
Pediatr Nephrol; 2011 Feb; 26(2):275-80. PubMed ID: 21107986
[TBL] [Abstract][Full Text] [Related]
9. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.
Aygun B; Mortier NA; Smeltzer MP; Hankins JS; Ware RE
Pediatr Nephrol; 2011 Aug; 26(8):1285-90. PubMed ID: 21559933
[TBL] [Abstract][Full Text] [Related]
10. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).
Youssry I; Makar S; Fawzy R; Wilson M; AbdAllah G; Fathy E; Sawires H
Pediatr Nephrol; 2015 Dec; 30(12):2163-8. PubMed ID: 26238275
[TBL] [Abstract][Full Text] [Related]
11. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
[TBL] [Abstract][Full Text] [Related]
12. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
Guasch A; Navarrete J; Nass K; Zayas CF
J Am Soc Nephrol; 2006 Aug; 17(8):2228-35. PubMed ID: 16837635
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria in Pediatric Neurogenic Bladder: Identifying an Earlier Marker of Renal Disease.
Millner RO; Preece J; Salvator A; McLeod DJ; Ching CB; Becknell B
Urology; 2019 Nov; 133():199-203. PubMed ID: 31454657
[TBL] [Abstract][Full Text] [Related]
14. Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.
Wada Y; Abe M; Moritani H; Mitori H; Kondo M; Tanaka-Amino K; Eguchi M; Imasato A; Inoki Y; Kajiyama H; Mimura T; Tomura Y
Exp Biol Med (Maywood); 2016 Oct; 241(16):1865-76. PubMed ID: 27216597
[TBL] [Abstract][Full Text] [Related]
15. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors.
Bolarinwa RA; Akinlade KS; Kuti MA; Olawale OO; Akinola NO
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):171-5. PubMed ID: 22237246
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.
Belisário AR; da Silva AA; Silva CV; de Souza LM; Wakabayashi EA; Araújo SA; Simoes-E-Silva AC
Biomark Med; 2019 Aug; 13(11):967-987. PubMed ID: 31390894
[TBL] [Abstract][Full Text] [Related]
17. [Urinary biomarkers of kidney dysfunction].
Piéroni L; Cristol JP
Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
[TBL] [Abstract][Full Text] [Related]
18. The nephropathy of sickle cell trait and sickle cell disease.
Ataga KI; Saraf SL; Derebail VK
Nat Rev Nephrol; 2022 Jun; 18(6):361-377. PubMed ID: 35190716
[TBL] [Abstract][Full Text] [Related]
19. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.
Ataga KI; Brittain JE; Moore D; Jones SK; Hulkower B; Strayhorn D; Adam S; Redding-Lallinger R; Nachman P; Orringer EP
Eur J Haematol; 2010 Sep; 85(3):257-63. PubMed ID: 20491879
[TBL] [Abstract][Full Text] [Related]
20. Changes in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.
Kord Valeshabad A; Wanek J; Saraf SL; Gaynes BI; Gordeuk VR; Molokie RE; Shahidi M
Am J Nephrol; 2015; 41(6):487-93. PubMed ID: 26278102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
